TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 38 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $48,000 | -49.5% | 43,670 | -51.8% | 0.00% | – |
| Q1 2018 | $95,000 | -43.8% | 90,510 | -29.2% | 0.00% | – |
| Q4 2017 | $169,000 | -55.8% | 127,749 | -41.4% | 0.00% | -100.0% |
| Q3 2017 | $382,000 | -12.6% | 218,036 | -5.2% | 0.00% | 0.0% |
| Q2 2017 | $437,000 | +199.3% | 229,946 | +823.1% | 0.00% | – |
| Q3 2016 | $146,000 | -47.3% | 24,911 | -60.0% | 0.00% | -100.0% |
| Q4 2015 | $277,000 | – | 62,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |